RecruitingNCT04472338

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

PATROL: Prostate Cancer Screening for People AT Genetic Risk FOr Aggressive Disease


Sponsor

University of Washington

Enrollment

450 participants

Start Date

May 21, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive). Studying samples of blood, urine, and/or tissue in the laboratory may help doctors further understand the genetics of prostate cancer and help identify ways to detect cancer earlier, thereby improving treatment and methods of early detection in the future.


Eligibility

Sex: MALEMin Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study is offering prostate cancer screening to people who have a known genetic mutation that increases their risk of developing aggressive prostate cancer. Because standard screening guidelines may not apply to high-genetic-risk individuals, this study aims to find the best early detection approach for this group. **You may be eligible if:** - You have a prostate and are 40 years of age or older - You have a confirmed inherited gene mutation known to increase prostate cancer risk (such as BRCA1, BRCA2, or others) **You may NOT be eligible if:** - You have already been diagnosed with prostate cancer - You have a medical condition that prevents you from safely undergoing the study procedures (such as prostate biopsy) - You received cancer treatment with curative intent within the past 12 months (for any cancer except non-melanoma skin cancer) - You have participated in another prostate cancer prevention trial for people with inherited genetic mutations Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBiospecimen Collection

Undergo collection of blood, urine, and/or tissue samples

OTHERLaboratory Biomarker Analysis

Correlative studies

OTHERQuality-of-Life Assessment

Ancillary studies

OTHERQuestionnaire Administration

Ancillary studies


Locations(8)

City of Hope

Duarte, California, United States

University of California, San Francisco

San Francisco, California, United States

Northwestern

Chicago, Illinois, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

OHSU Knight Cancer Institute

Portland, Oregon, United States

University of Pennsylvania/Abramson Cancer Center

Philadelphia, Pennsylvania, United States

University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04472338


Related Trials